Cell Cycle Deregulation in Cancer (Record no. 110467)

000 -LEADER
fixed length control field 03925nam a22004575i 4500
001 - CONTROL NUMBER
control field 978-1-4419-1770-6
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140220084507.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100316s2010 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781441917706
-- 978-1-4419-1770-6
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-4419-1770-6
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC261-271
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 614.5999
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Enders, Greg H.
Relator term editor.
245 10 - TITLE STATEMENT
Title Cell Cycle Deregulation in Cancer
Medium [electronic resource] /
Statement of responsibility, etc edited by Greg H. Enders.
264 #1 -
-- New York, NY :
-- Springer New York,
-- 2010.
300 ## - PHYSICAL DESCRIPTION
Extent VIII, 206p. 19 illus., 11 illus. in color.
Other physical details online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# - SERIES STATEMENT
Series statement Current Cancer Research
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Starting the Cell Division Cycle -- Escape from Cellular Quiescence -- Interplay Between Cyclin-Dependent Kinases and E2F-Dependent Transcription -- Regulation of Pre-RC Assembly: A Complex Symphony Orchestrated by CDKs -- Proliferation Under Duress -- Mitotic Checkpoint and Chromosome Instability in Cancer -- Mitotic Catastrophe -- p53, ARF, and the Control of Autophagy -- Long-Term Proliferation -- Regulation of Self-Renewing Divisions in Normal and Leukaemia Stem Cells -- Maintenance of Telomeres in Cancer -- The Senescence Secretome and Its Impact on Tumor Suppression and Cancer -- Applications in Preventing and Treating Cancer -- Cell Cycle Deregulation in Pre-neoplasia: Case Study of Barrett’s Oesophagus -- Targeting Cyclin-Dependent Kinases for Cancer Therapy.
520 ## - SUMMARY, ETC.
Summary, etc Modern studies of regulation of the cell division cycle were pioneered by Leland Hartwell, Paul Nurse, and Tim Hunt in yeast and marine invertebrates. This work identified proteins termed cyclins that fluxuate in abundance during progression through the cycle and partner with Cyclin dependent kinases (Cdks) to drive major cell cycle transitions. Much has been learned since about how these and other proteins control cell cycle progression in all eukaryotes, including man. Further research is uncovering how these controls are de-regulated in cancer, a disease of unbridled cell proliferation that is the leading cause of death in developed countries. However, there is much more to be learned, and the hard won gains are just beginning to impact cancer care. In 11 reviews by leading experts, this volume lays out the current state and directions of the field for biomedical scientists of all training levels. The collection begins with three reviews that delineate how cells initiate the cell cycle, from growth factor stimulation to activation of key transcription programs and origins of DNA replication. The next three reviews address issues of proliferation under duress, including how derangement of mitotic checkpoints can lead to cell death or genetic instability and how recycling of intracellular molecules (autophagy) is regulated. The next three reviews address the special context of long-term proliferation—how it is regulated in stem cells, how it can erode telomeric structures on the tips of chromosomes, and how it can culminate in senescence. The last two reviews describe how cell cycle advances are beginning to touch patients, in the characterization of pre-malignant states and in cancer therapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Toxicology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomedicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer Research.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology/Toxicology.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781441917690
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Current Cancer Research
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-4419-1770-6
912 ## -
-- ZDB-2-SME

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue